PACB

Pacific Biosciences of California Inc
9.61
0.37 (4.0%)
Company Name Stock Ticker Symbol Market Type
Pacific Biosciences of California Inc PACB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.37 4.0% 9.61 17:34:35
Open Price Low Price High Price Close Price Prev Close
9.15 9.01 9.70 9.61 9.24
more quote information »

Recent News

Date Time Source Heading
3/17/202317:32EDGARStatement of Changes in Beneficial Ownership (4)
3/14/202309:05PRNUSPacBio Announces a New Informatics Analysis Method for..
3/07/202307:05PRNUSPacBio To Begin Commercial Shipment of Revio Systems
3/06/202316:54EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202316:51EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202316:48EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202316:44EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202316:40EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202317:02EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/27/202307:00PRNUSPacBio to Present at Cowen's 43rd Annual Health Care..
2/22/202307:40EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202307:35EDGARStatement of Changes in Beneficial Ownership (4)
2/16/202316:02PRNUSPacBio Announces Fourth Quarter and Fiscal Year 2022..
2/13/202316:04EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202315:56EDGARSchedule 13g
(sc 13g/a)
2/10/202313:48EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202310:30EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202306:04EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202311:46EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202309:05PRNUSPacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk..
2/03/202316:37EDGARAmended Statement of Ownership (sc 13g/a)
2/03/202306:11EDGARAmended Statement of Ownership (sc 13g/a)
2/02/202316:02PRNUSPacBio to Report Fourth Quarter and Full Year 2022 Financial..
1/27/202316:06EDGARCurrent Report Filing (8-k)
1/25/202306:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/24/202323:18PRNUSPacific Biosciences of California, Inc. Announces Pricing of..
1/24/202317:13EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/24/202316:44EDGARCurrent Report Filing (8-k)
1/24/202316:05PRNUSPacific Biosciences of California, Inc. Announces Proposed..
1/13/202310:04PRNUSPacBio Celebrates Nature Methods Naming Long-Read Sequencing..
1/11/202318:30EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202307:42EDGARCurrent Report Filing (8-k)
1/09/202307:05PRNUSPacBio Announces Record Orders, Including Orders for 76..
1/09/202307:00PRNUSPacBio and the University of Tokyo Announce Bioinformatics..
12/28/202216:05PRNUSPacBio to Present at 41st Annual J.P. Morgan Healthcare..
12/06/202209:05PRNUSPacBio and Boston Children's Hospital Collaborate to..
12/02/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
11/18/202207:05TRMNJ.P. Morgan Remains a Buy on Pacific Biosciences (PACB)
11/11/202216:05PRNUSPacBio to Present at Upcoming Investor Conferences
11/07/202216:05PRNUSPacBio Announces Third Quarter 2022 Financial Results
11/02/202209:05PRNUSPacBio Announces that Euan Ashley, M.D., Ph.D., Joseph..
10/25/202223:04PRNUSPacBio Announces Revio, a Revolutionary New Long Read..
10/25/202222:30PRNUSPacBio Announces Onso, the Highly Accurate Short-Read..
10/25/202222:29PRNUSPacBio to Report Third Quarter Earnings on November 7 and..
10/20/202209:05PRNUSPacBio Launches Single-Cell Transcriptome Solution Ushering..
10/19/202209:05PRNUSPacBio and Twist Bioscience Deliver Initial Portfolio of..
10/18/202209:05PRNUSPacBio Collaborates with Leading Researchers to Establish..
10/03/202208:22EDGARStatement of Changes in Beneficial Ownership (4)
9/27/202209:05PRNUSPacBio Unveils a New Method for Comprehensive, Genome-wide..
9/07/202216:05PRNUSPacBio to Participate in the Morgan Stanley 20th Annual..